Refresh

Jubilant Pharmova Ltd. - Research Center

530019 JUBLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Sales

205.80 175.20 186.30 217.40 199.84

Operating profit

12.20 -0.70 0.80 4.20 2.18

Interest

8.10 8.30 7.10 6.40 5.70

Gross profit

54.20 10.00 12.10 13.70 10.14

EPS (Rs)

2.04 -0.15 -0.03 0.12 -1.94
Quarterly  results in details
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Other income

50.10 19.00 18.40 15.90 13.66

Stock adjustment

19.30 -1.20 -10.30 31.20 12.58

Raw material

74.10 69.10 94.90 71.90 90.39

Power and fuel

- - - - -

Employee expenses

46.50 49.90 46.10 47.50 40.07

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

53.70 58.10 54.80 62.60 54.62

Provisions made

- - - - -

Depreciation

12.70 12.30 11.90 11.40 11.37

Taxation

9.00 0.10 0.60 0.40 29.63

Net profit / loss

32.50 -2.40 -0.40 1.90 -30.86

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

15.90 15.90 15.90 15.90 15.93

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

5.93 -0.40 0.43 1.93 1.09

GPM (%)

21.18 5.15 5.91 5.87 4.75

NPM (%)

12.70 -1.24 -0.20 0.81 -14.45
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com